Childhood Cancer Survivor Study

Complete Title: CHMC-M002: Childhood Cancer Survivor Study (IRB# 11257)
Trial Phase: N/A
Investigator: K. Scott Baker

The Childhood Cancer Survivor Study (CCSS) will investigate the long-term effects of cancer and its associated therapies. A retrospective cohort study will be conducted through a multi-institutional collaboration, which will involve the identification and active follow-up of a cohort of approximately 50,000 survivors of cancer, diagnosed before 21 years of age, between 1970 and 1999 and 10,000 sibling controls. This project will study children and young adults exposed to specific therapeutic modalities, including radiation, chemotherapy, and/or surgery, who are at increased risk of late-occurring adverse health outcomes. A group of sibling controls will be identified and data collected for comparison purposes.

Keywords:
  • Bone Cancer
  • Central Nervous System (CNS)
  • Hematologic Malignancies
  • Kidney Cancer
  • Leukemia
  • Lymphoma
  • Pediatric Cancers, Miscellaneous
  • Neuroblastoma
  • Sarcoma
  • Solid Tumors
  • Wilms' Tumor
  • Neoplasms
  • Rhabdomyosarcoma
  • Sarcoma, Soft Tissue
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Checklist icon

Join a Clinical Trial

Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.

Contact Us

If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.

Adult
Pediatric
N/A
K. Scott Baker
CHMC-M002
NCT01120353
CHMC-M002: Childhood Cancer Survivor Study (IRB# 11257)
Bone Cancer
Central Nervous System (CNS)
Hematologic Malignancies
Kidney Cancer
Leukemia
Lymphoma
Pediatric Cancers, Miscellaneous
Neuroblastoma
Sarcoma
Solid Tumors
Wilms' Tumor
Neoplasms
Rhabdomyosarcoma
Sarcoma, Soft Tissue